tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IMCR Stock Latest News

Immunocore’s Innovative Approach: A New Hope for PRAME-Positive Cancer Treatment
Company AnnouncementsImmunocore’s Innovative Approach: A New Hope for PRAME-Positive Cancer Treatment
2d ago
IMCR
Immunocore’s Phase 3 Melanoma Study: A Potential Game Changer?
PremiumCompany Announcements
Immunocore’s Phase 3 Melanoma Study: A Potential Game Changer?
2d ago
IMCR
Immunocore’s Promising Melanoma Study: A Potential Game-Changer
PremiumCompany Announcements
Immunocore’s Promising Melanoma Study: A Potential Game-Changer
2d ago
IMCR
Immunocore’s Brenetafusp: A Promising Study in PRAME-Positive Cancers
PremiumCompany Announcements
Immunocore’s Brenetafusp: A Promising Study in PRAME-Positive Cancers
2d ago
IMCR
Immunocore’s Innovative Cancer Study: A Potential Game-Changer for Investors
PremiumCompany Announcements
Immunocore’s Innovative Cancer Study: A Potential Game-Changer for Investors
2d ago
IMCR
Immunocore Holdings: Buy Rating Backed by Promising Clinical Data and Strategic Positioning
PremiumRatingsImmunocore Holdings: Buy Rating Backed by Promising Clinical Data and Strategic Positioning
8d ago
IMCR
Immunocore assumed with a Neutral at Guggenheim
Premium
The Fly
Immunocore assumed with a Neutral at Guggenheim
1M ago
IMCR
Immunocore’s Earnings Call Highlights Robust Growth and Strategic Expansion
Premium
Company Announcements
Immunocore’s Earnings Call Highlights Robust Growth and Strategic Expansion
3M ago
IMCR
Immunocore Holdings: Strong Revenue Growth and Clinical Advancements Justify Buy Rating
PremiumRatings
Immunocore Holdings: Strong Revenue Growth and Clinical Advancements Justify Buy Rating
3M ago
IMCR
Immunocore Holdings Reports Strong Revenue Growth
PremiumCompany Announcements
Immunocore Holdings Reports Strong Revenue Growth
3M ago
IMCR
Immunocore Holdings: Strong Performance and Promising Outlook Drive Buy Rating
PremiumRatings
Immunocore Holdings: Strong Performance and Promising Outlook Drive Buy Rating
3M ago
IMCR
Immunocore Holdings: Strong Kimmtrak Performance and Strategic Expansion Justify Buy Rating
PremiumRatings
Immunocore Holdings: Strong Kimmtrak Performance and Strategic Expansion Justify Buy Rating
3M ago
IMCR
Immunocore reports Q2 EPS (20c), consensus (21c)
PremiumThe FlyImmunocore reports Q2 EPS (20c), consensus (21c)
3M ago
IMCR
Immunocore Holdings’ Promising PRAME-Targeting Therapies Drive Buy Rating
Premium
Ratings
Immunocore Holdings’ Promising PRAME-Targeting Therapies Drive Buy Rating
5M ago
IMCR
AMD, Block upgraded: Wall Street’s top analyst calls
Premium
The Fly
AMD, Block upgraded: Wall Street’s top analyst calls
5M ago
AMD
FLD
Immunocore initiated with a Buy at Deutsche Bank
PremiumThe Fly
Immunocore initiated with a Buy at Deutsche Bank
5M ago
IMCR
Immunocore Holdings Secures Shareholder Approval at AGM
PremiumCompany Announcements
Immunocore Holdings Secures Shareholder Approval at AGM
6M ago
8K
IMCR
Immunocore price target raised to $86 from $85 at Oppenheimer
PremiumThe Fly
Immunocore price target raised to $86 from $85 at Oppenheimer
6M ago
IMCR
Immunocore Holdings Reports Strong Q1 2025 Performance
PremiumCompany Announcements
Immunocore Holdings Reports Strong Q1 2025 Performance
6M ago
IMCR
Immunocore price target lowered to $52 from $66 at Barclays
PremiumThe FlyImmunocore price target lowered to $52 from $66 at Barclays
6M ago
IMCR
Immunocore Holdings: Strong Sales Growth and Financial Position Justify Buy Rating
Premium
Ratings
Immunocore Holdings: Strong Sales Growth and Financial Position Justify Buy Rating
6M ago
IMCR
Immunocore Holdings: Strong International Growth and Promising Clinical Trials Drive Buy Recommendation
Premium
Ratings
Immunocore Holdings: Strong International Growth and Promising Clinical Trials Drive Buy Recommendation
6M ago
IMCR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >